Cochlear Corporation Nucleus CI
Cochlear Corporation, located in Australia, developed
and pioneered the cochlear implant. Their CI is called the Nucleus.
December 2000 - The FDA has approved the newest Cochlear
Implant from Cochlear Corporation. Called the Nucleus
24 Contour, this system places the electrode array closer to the
auditory nerve for improved performance.
April 2001 -
Cochlear Corporation announces that their Nucleus 24 implant will soon
incorporate
a Phonak FM System.
March 2002 -
FDA Approves ESPrit(TM) 3G Behind The Ear Speech Processor
September
2003 - Cochlear announces their next generation
implant.
November 2003 - Here's
our report on the Cochlear presentation at ALDAcon 2003.
March
2007 - Cochlear Americas CI Presentation
June
2007 - Cochlear Americas Streamlines CI Care
July 2007 - Cochlear Announces CI
Products for Kids
July 2007 - Educators Guide to
Cochlear Implants
August 2007 - Cochlear's net profit cracks $100m barrier
February 2008 - Cochlear Americas Nucleus Freedom Sound
Processor Compatibile for All Nucleus Implants
April 2008 - Interview about Cochlear's new mapping
software
June 2008 - Cochlear: Nucleus Freedom is still the most
reliable implant device on the market
July 2008 - Cochlear Has Provided 120,000 Nucleus(R)
Cochlear Implants
~~~~~~~~~~~~~~~~~~~
Editor: Cochlear Corporation has just announced its next-generation
cochlear implant (CI). The big advantage over current CIs is an
increased ability to upgrade the CI as technological improvements
happen. In particular, the new CI will support upgrades in coding
strategy, something current CIs can't do. Here are portions of the press
release.
~~~~~~~~~~~~~~~~~~~
DENVER - August 2003 - Cochlear Americas, manufacturer of the
Cochlear Nucleus(r) line of implants and the world leader in cochlear
implant technology, has forged yet another frontier in cochlear implant
research - the percutaneous Contour AdvanceT cochlear implant. The
percutaneous implant is a special type of cochlear implant that allows
researchers to externally manipulate coding strategies. Coding
strategies are the techniques used by the speech processor to translate
sound into the signals the implant sends to the cochlea.
This new research platform is currently under clinical trials and not
yet commercially available. The trials are designed to accelerate the
development of new coding strategies to provide future patients with
more advanced options. This type of research cannot be implemented with
existing cochlear implants since the electronics are housed in the
internal implant. The findings of the research will be applied to the
design of Cochlear's future generations of cochlear implants. This
research is being done in collaboration with the Research Triangle
Institute and Duke University in Durham, North Carolina and Rocky
Mountain Cochlear Implant Center in Denver, Colorado. The first patient
to receive a cochlear implant with a percutaneous plug was implanted
last month at Duke University.
[snip]
"We feel that the next major breakthrough in cochlear implant
performance will be the result of advanced coding strategies," said
Jim Miller, President, Cochlear Americas. "We are delighted that
Dr. van den Honert will be leading us in this endeavor and hope that the
research will result in future developments and opportunities for
cochlear implant recipients."
~~~~~~~~~~~~~~~~~
August 2007
Hearing implant company Cochlear has reported a
full year net profit of $100.13 million, a rise of 25 per cent. Core
earnings were up 24 per cent to $107.56 million for 2006/07, which
exceeded the company's guidance of $100 million. Looking ahead to fiscal
2008, the company said core earnings profit could grow by approximately 15
to 20 per cent. "The outlook is for continued core earnings growth of
approximately 15 to 20 per cent, depending on the strength and rapidity of
the Australian dollar's appreciation," Cochlear said. . . . Total sales of
Cochlear's implants jumped by 24 per cent on last year, with 15,947 units
sold. Total revenue for the year was $559.4 million, which too was a 24
per cent increase on 2006.
Full Story
~~~~~~~~~~~~~~~~~
Cochlear Americas, a leader in cochlear implant
technology, has announced the flagship Nucleus Freedom sound processor is
now compatible with all previous Nucleus generation implants. This means
that recipients implanted with earlier technology like Nucleus 22, Nucleus
24 ABI and Nucleus 24 Double Array implants can benefit from the latest
hearing technology.
"This new compatibility demonstrates Cochlear's
lifetime commitment to all of our Nucleus implant recipients," says Chris
Smith, president, Cochlear Americas. "Recipients implanted over 20 years
ago can now enjoy many of the same benefits of future implant recipients.
These innovations provide users with the freedom to enjoy music and handle
even the most challenging situations such as conversations in a noisy
restaurant as well as sports and activities around water."
The Nucleus Freedom sound processor is the fifth
upgrade for Nucleus 22 recipients and is designed to provide water and
sweat resistance; superior hearing performance in a variety of
environments with Cochlear's SmartSound 2 innovation technology;
rechargeable and/or disposable battery options; digital technology to
provide clear sound; an array of wearing options and colors.
More information is available at
www.cochlear.com.
~~~~~~~~~~~~~~~~~
April 2008
Dybala: Now, tell us about your new cochlear
implant software platform. What are the main components of the Custom
Sound Suite 2.0?
Markos: Custom Sound Suite 2.0 is comprised of two
different software programs: Custom Sound 2.0 and Custom Sound EP 2.0. It
is used by clinicians to program all Nucleus devices, and it has new,
great features that are designed to enhance the hearing experience for all
of our recipients. The key components that I would like to highlight are
Implant ID, SmartSound 2, which are our preprocessing strategies; the new
Hearing Mentor; and Freedom for Nucleus 22.
Full Story
~~~~~~~~~~~~~~~~~
June 2008
For more than 25 years, Cochlear has delivered the
most reliable implant devices. Each new generation of Nucleus implants has
been more reliable than the last, and Nucleus Freedom is no exception. Our
3 year Cumulative Survival Percentage (CSP) data demonstrates that Freedom
is still the most reliable implant device on the market. The graphs below
show how the Nucleus Freedom device compares in reliability to the other
cochlear implant manufacturers.
Full Story
